Investment rationale for PE financing of international merger in the nano technology space

By | | No Comments

Need:

A leading technology provider in the nano-liquid space had decided to merge with a European manufacturer of plastic disposables.

Assignment

MSC was contracted by the company’s Chairman because of a previous strategy assignment MSC had performed. The client had engaged in merger discussions with a larger company and asked MSC to participate in a workshop together with executives from the management of the two companies. The synergies were clear, and a term sheet was drafted by the two CEOs. To enable the merger, the shares needed to be bought from the owner of one of the companies and a Board member from a major private equity company had thus been invited. MSC worked as deal facilitator throughout the process and created the presentation that was used by the PE company to make its investment decision. A bidding process with a handful of interested parties followed but unfortunately, the PE company on our client’s side ended up in second place.

Continuous competitor and business opportunity surveillance across multiple indications

By | | No Comments

Need:

A leading biotech company had grown its asset portfolio into multiple indications and needed a way enable its management and board directors to stay on top new threats and opportunities across multiple markets.

Assignment

MSC’s long standing relationship with the client as deal-making support made MSC a natural choice to deliver insights from CI surveillance. Together with the client, a format was designed that enabled efficient screening of relevant deals, competitor updates and new opportunities as they emerged. The assignment led to a monthly delivery that ensures that the client keeps up to date for discussions with shareholders, strategic partners and investors.